The assessment and management of hypoactive delirium.
نویسندگان
چکیده
While serving as the on-call physician for a nursing home, you are contacted by the floor nurse about A.R., a 78-year-old woman who refused her medications and physical therapy. A.R. was transferred to the nursing home one week earlier for skilled rehabilitation after an elective and uneventful bio-prosthetic aortic valve replacement. Her medical history includes mild Alzheimer’s dementia, bilateral cataracts, congestive heart failure, hyperlipidemia, hypertension, chronic renal insufficiency, osteoporosis, osteoarthritis, urinary incontinence, and multiple urinary tract infections. She has been widowed for five years, and lives in a house with her daughter. Medications include enteric-coated aspirin 81 mg daily, furosemide 40 mg twice daily, potassium chloride 20 mEq daily, atorvastatin 40 mg daily, lisinopril 2.5 mg daily, metoprolol XL 100 mg daily, alendronate 70 mg weekly, acetaminophen/hydrocodone (500/5) 1-2 tabs every 4-6 hr. as needed, ciprofloxacin 250 mg twice daily, zolpidem 5 mg at bedtime, and donepezil 5 mg at bedtime. Her appetite has been only fair since her arrival at the nursing home, and her last bowel movement was two days prior. A Foley catheter has been in place since her hospitalization. The nurse notes that A.R. is slightly more lethargic, a departure from one day earlier, when she cooperated with physical therapy and was pleasant to nurses. The nurse requests that you evaluate A.R. Physical examination is unremarkable. A.R. answers all your questions appropriately, and scores a 26/30 on a Folstein Mini-Mental Examination—an identical score to one conducted prior to surgery. You order laboratory tests and consider the differential diagnosis for A.R.’s fatigue and noncompliance with medication.
منابع مشابه
Delirium Management in Patients with Cancer: Dosing of Antipsychotics in the Delirium Subtypes and Response to Psychopharmacological Management
Background: While delirium resolution and persistent delirium in hypoactive and hyperactive delirium have been studied to a certain extent, doses of antipsychotics administered remain unknown. Methods: Patients treated for cancer were recruited at the Memorial Sloan Kettering Cancer Center (MSKCC). Sociodemographic, medical variables, the Memorial Delirium Assessment Scale (MDAS) subitems (1–10...
متن کاملConsensus and variations in opinions on delirium care: a survey of European delirium specialists
BACKGROUND There are still substantial uncertainties over best practice in delirium care. The European Delirium Association (EDA) conducted a survey of its members and other interested parties on various aspects of delirium care. METHODS The invitation to participate in the online survey was distributed among the EDA membership. The survey covered assessment, treatment of hyperactive and hypo...
متن کاملمقایسه اثر هالوپریدول و میدازولام و پلاسبو در درمان دلیریوم در موشهای صحرایی نر بالغ براساس تغییرات رفتاری
Abstract: purpose: Delirium is change in consciousness and ability to focus and attention . it is reducing costs and increasing the time patients stay in hospital . While sedative and hypnotic drugs reduce pain and anxiety , but according to sources , it is one of the risk factors of delirium . Haloperidol because of low anticholinergic activity and low drug interactions and metabolites hav...
متن کاملPrognostic effects of delirium motor subtypes in hospitalized older adults: A prospective cohort study
OBJECTIVES To investigate the association between delirium motor subtypes and hospital mortality and 12-month mortality in hospitalized older adults. DESIGN Prospective cohort study conducted from 2009 to 2015. SETTING Geriatric ward of a university hospital in Sao Paulo, Brazil. PARTICIPANTS We included 1,409 consecutive admissions of acutely ill patients aged 60 years and over. We exclu...
متن کاملAgitation and delirium at the end of life: "We couldn't manage him".
Delirium is the most common neuropsychiatric complication experienced by patients with advanced illness, occurring in up to 85% of patients in the last weeks of life. Using the case of Mr L, a 59-year-old man with metastatic lung cancer who developed an agitated delirium in the last week of life, we review the evaluation and management of delirium near the end of life. Although some studies hav...
متن کاملIdentifying the barriers and enablers to palliative care nurses' recognition and assessment of delirium symptoms: a qualitative study.
CONTEXT Delirium is underrecognized by nurses, including those working in palliative care settings where the syndrome occurs frequently. Identifying contextual factors that support and/or hinder palliative care nurses' delirium recognition and assessment capabilities is crucial, to inform development of clinical practice and systems aimed at improving patients' delirium outcomes. OBJECTIVES T...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Medicine and health, Rhode Island
دوره 90 12 شماره
صفحات -
تاریخ انتشار 2007